Up to 30% of protein encoding genes are regulated by microRNAs (miRNAs). The miRNAs are abundantly expressed in the brain, and, in particular, during brain development stages. Some miRNAs are essential regulators of left/ right neuronal asymmetry in an invertebrate and brain development in vertebrates. Transfection of some microRNA (miR-124) in human cells changed the expression pattern of mRNAs towards brain-like profiles. It may be expected, therefore, that miRNA-related mechanisms are involved in certain aspects of neuropsychiatric pathologies. The data have been obtained suggesting that depletion of cellular components controlling miRNA processing and biogenesis severely affects brain functions implicated in pathogenesis of neurodegenerative or behavior diseases. Partial or conditional loss of function for Dicer causes loss of dopamine neurons and degeneration of Purkinje cells – mechanisms implicated in Parkinson disease; or enhance neurodegeneration in Drosophila model induced by proteins implicated in polyQ neurodegenerative pathologies. Loss of FMPR protein function is a cause of common mental retardation syndrome (FXS) and function of FMRP or FMPR-related protein in Drosophila (Dfmr1) was linked to RNA-induced silencing complex (RISC). Mutation in putative target for miRNA in SLITRK1 gene is associated with Tourette's neuropsychiatric disorder- the most direct known to date example of linkage between behavior disease and specific miRNA. The pilot studies demonstrated that despite the tiny size miRNAs are quite stable in postmortem tissues and that convergent approach in study of expression and genetic variability of miRNAs in neuropsychiatric pathology is a conceivable goal. It is anticipated that comprehensive studies of miRNA regulators and their targets using innovative genomic technologies may shed a light on unknown aspects in pathogenesis of common neurodegenerative disorders (Alzheimer's disease) and mental disorders (schizophrenia) in a nearest future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American College of Obstetricians and Gynecologists Committee on Genetics (2006) ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol 107:1483-1485
Abelson JF, Kwan KY, O’Roak BJ et al. (2005) Sequence variants in SLITRK1 are associated with Tourette’s syndrome. Science 310:317-320
Bassett AS, Chow EW, AbdelMalik P et al. (2003) The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatr 160:1580-1586
Bernstein E, Kim SY, Carmell MA et al. (2003) Dicer is essential for mouse development. Nat Genet 35:215-217
Bilen J, Liu N, Bonini NM (2006) A new role for microRNA pathways: modulation of degen-eration induced by pathogenic human disease proteins. Cell Cycle 5:2835-2838
Brennecke J, Hipfner DR, Stark A et al. (2003) Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113:25-36
Burmistrova OA, Goltsov AY, Abramova LI et al. (2007) MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Mosc) 72:578-582
Caudy AA, Myers M, Hannon GJ et al. (2002) Fragile X-related protein and VIG associate with the RNA interference machinery. Genes Dev 16:2491-2496
Chen K, Rajewsky N (2006) Deep conservation of microRNA-target relationships and 3∋ΥΤΡ motifs in vertebrates, flies, and nematodes. Cold Spring Harb Symp Quant Biol 71:149-156
Cheng HY, Papp JW, Varlamova O et al. (2007) microRNA modulation of circadian-clock period and entrainment. Neuron 54:813-829
Davis CJ, Bohnet SG, Meyerson JM et al (2007) Sleep loss changes microRNA levels in the brain: a possible mechanism for state-dependent translational regulation. Neurosci Lett 422:68-73
Giraldez AJ, Cinalli RM, Glasner ME et al. (2005) MicroRNAs regulate brain morphogenesis in zebrafish. Science 308:833-838
Gitlin L, Karelsky S, Andino R (2002) Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418:430-434
Greco SJ, Rameshwar P (2007) MicroRNAs regulate synthesis of the neurotransmitter sub-stance P in human mesenchymal stem cell-derived neuronal cells. Proc Natl Acad Sci USA 104:15484-15489
Hansen T, Olsen L, Lindow M et al. (2007) Brain expressed microRNAs implicated in Schizophrenia etiology. PLoS ONE 2:e873
Horowitz A, Shifman S, Rivlin N et al. (2005) A survey of the 22q11 microdeletion in a large cohort of schizophrenia patients. Schizophr Res 73:263-267
Ishizuka A, Siomi MC, Siomi H (2002) A Drosophila fragile X protein interacts with compo-nents of RNAi and ribosomal proteins. Genes Dev 16:2497-2508
Iwai N, Naraba H (2005) Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 331:1439-1444
Jin P, Alisch RS, Warren ST (2004) RNA and microRNAs in fragile X mental retardation. Nat Cell Biol 6:1048-1053
John B, Enright AJ, Aravin A et al. (2004) Human MicroRNA targets. PLoS Biol 2:e363
Johnston RJ, Hobert O (2003) A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature 426:845-849
Karayiorgou M, Gogos JA (2004) The molecular genetics of the 22q11-associated schizophrenia. Brain Res Mol Brain Res 132:95-104
Kennedy S, Wang D, Ruvkun G (2004) A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans. Nature 427:645-649
Krichevsky AM, King KS, Donahue CP et al. (2003) A microRNA array reveals extensive regulation of microRNAs during brain development. RNA 9:1274-1281
Kumar P, Wu H, McBride JL et al. (2007) Transvascular delivery of small interfering RNA to the central nervous system. Nature 448:39-43
Landgraf P, Rusu M, Sheridan R et al. (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414
Landthaler M, Yalcin A, Tuschl T (2004) The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 14:2162-2167
Leaman D, Chen PY, Fak J et al. (2005) Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development. Cell 121:1097-1108
Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20
Lim LP, Lau NC, Garrett-Engele P et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773
Makeyev EV, Zhang J, Carrasco MA et al. (2007) The MicroRNA miR-124 promotes neuro-nal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol Cell 27:435-448
Miska EA, Varez-Saavedra E, Townsend M et al. (2004) Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5:R68
Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaper-ones. Nat Rev Neurosci 6:11-22
Nelson PT, Baldwin DA, Kloosterman WP et al. (2006) RAKE and LNA-ISH reveal micro-RNA expression and localization in archival human brain. RNA 12:187-191
Okamura K, Ishizuka A, Siomi H et al. (2004) Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways. Genes Dev 18:1655-1666
O’Neill JS, Hastings MH (2007) Circadian clocks: timely interference by MicroRNAs. Curr Biol 17:R760-R762
Perkins DO, Jeffries C, Sullivan P (2005) Expanding the ‘central dogma’: the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Mol Psychiatr 10:69-78
Pfeffer S, Sewer A, Lagos-Quintana M et al. (2005) Identification of microRNAs of the her-pesvirus family. Nat Methods 2:269-276
Rogaev EI (2005) Small RNAs in human brain development and disorders. Biochemistry (Mosc) 70:1404-1407
Sathyan P, Golden HB, Miranda RC (2007) Competing interactions between micro-RNAs determine neural progenitor survival and proliferation after ethanol exposure: evidence from an ex vivo model of the fetal cerebral cortical neuroepithelium. J Neurosci 27:8546-8557
Schaefer A, O’Carroll D, Tan CL et al. (2007) Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 204:1553-1558
Schratt GM, Tuebing F, Nigh EA et al. (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289
Simmer F, Tijsterman M, Parrish S et al. (2002) Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr Biol 12:1317-1319
Todd PK, Mack KJ, Malter JS (2003) The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc Natl Acad Sci USA 100:14374-14378
Vaisse C, Halaas JL, Horvath CM et al. (1996) Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95-97
Wong KK, DeLeeuw RJ, Dosanjh NS et al. (2007) A comprehensive analysis of common copy-number variations in the human genome. Am J Hum Genet 80:91-104
Xie X, Lu J, Kulbokas EJ et al. (2005) Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434:338-345
Xu P, Vernooy SY, Guo M et al. (2003) The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13:790-795
Zalfa F, Eleuteri B, Dickson KS et al. (2007) A new function for the fragile X mental retarda-tion protein in regulation of PSD-95 mRNA stability. Nat Neurosci 10:578-587
Kim J, Inoue K, Ishii J et al. (2007) A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317:1220-1224
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media B.V
About this chapter
Cite this chapter
Rogaev, E.I., Islamgulov, D.V., Grigorenko, A.P. (2008). MicroRNA in Neuropsychiatric Diseases. In: Ying, SY. (eds) Current Perspectives in microRNAs (miRNA). Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8533-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8533-8_13
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8532-1
Online ISBN: 978-1-4020-8533-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)